Arbutus Biopharma Corporation (ABUS)
NASDAQ: ABUS · IEX Real-Time Price · USD
2.50
-0.04 (-1.57%)
At close: Dec 29, 2023, 4:00 PM
2.48
-0.02 (-0.80%)
After-hours: Dec 29, 2023, 7:58 PM EST
Arbutus Biopharma Stock Forecast
Stock Price Forecast
According to 3 stock analysts, the average 12-month stock price forecast for ABUS stock stock is $6.00, which predicts an increase of 140.00%. On average, analysts rate ABUS stock stock as a strong buy.
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 12, 2023.
Analyst Ratings
The average analyst rating for ABUS stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '23 | Aug '23 | Sep '23 | Oct '23 | Nov '23 | Dec '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +140.00% | Sep 12, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +140.00% | Aug 4, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +140.00% | Aug 4, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +140.00% | Jul 11, 2023 |
| JMP Securities | JMP Securities | Buy Reiterates $6 | Buy | Reiterates | $6 | +140.00% | Jul 6, 2023 |
Financial Forecast
Revenue This Year
21.21M
from 39.02M
Decreased by -45.65%
Revenue Next Year
14.82M
from 21.21M
Decreased by -30.14%
EPS This Year
-0.46
from -0.46
EPS Next Year
-0.45
from -0.46
Revenue Forecast
| Revenue | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | 22.8M | 21.2M | 19.5M | 10.0M | 56.4M |
| Avg | 21.2M | 14.8M | 13.9M | 9.8M | 54.8M |
| Low | 19.7M | 4.5M | 8.5M | 9.4M | 52.6M |
Revenue Growth
| Revenue Growth | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | -41.6% | -0.0% | 31.8% | -27.8% | 477.8% |
| Avg | -45.6% | -30.1% | -6.1% | -29.9% | 461.3% |
| Low | -49.5% | -78.7% | -42.5% | -32.6% | 439.3% |
EPS Forecast
| EPS | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | -0.45 | -0.37 | -0.39 | -0.37 | -0.18 |
| Avg | -0.46 | -0.45 | -0.41 | -0.36 | -0.17 |
| Low | -0.45 | -0.57 | -0.43 | -0.34 | -0.17 |
EPS Growth
| EPS Growth | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.